Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Celiac disease and catatonia: more than a coincidence?
CONCLUSIONS: Even without gastrointestinal manifestations, CD may present with neuropsychiatric symptoms. According to this case report, CD should be investigated in patients with unexplained catatonia, and that CD may only present with neuropsychiatric symptoms.PMID:36866995 | DOI:10.24953/turkjped.2022.411 (Source: The Turkish Journal of Pediatrics)
Source: The Turkish Journal of Pediatrics - March 3, 2023 Category: Pediatrics Authors: P ınar Özbudak Alev El çi Karaduman Deniz Karg ın Menderes Hakan Öztürk K ıvılcım Gücüyener Source Type: research
Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (M < sup > pro < /sup > ) by using STD-NMR spectroscopy, in silico studies and antiviral assays
This study demonstrates the importance of drug repurposing against emerging and neglected diseases. This study also exhibits successful application of STD-NMR spectroscopy and plaque reduction assay in rapid identification of potential anti-viral agents.PMID:36740128 | DOI:10.1016/j.ijbiomac.2023.123540 (Source: International Journal of Biological Macromolecules)
Source: International Journal of Biological Macromolecules - February 5, 2023 Category: Biochemistry Authors: A Mateen Khan None Atia-Tul-Wahab Saba Farooq None Asmatullah M Iqbal Choudhary Source Type: research
Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (M < sup > pro < /sup > ) by using STD-NMR spectroscopy, in silico studies and antiviral assays
This study demonstrates the importance of drug repurposing against emerging and neglected diseases. This study also exhibits successful application of STD-NMR spectroscopy and plaque reduction assay in rapid identification of potential anti-viral agents.PMID:36740128 | PMC:PMC9896891 | DOI:10.1016/j.ijbiomac.2023.123540 (Source: International Journal of Biological Macromolecules)
Source: International Journal of Biological Macromolecules - February 5, 2023 Category: Biochemistry Authors: A Mateen Khan None Atia-Tul-Wahab Saba Farooq None Asmatullah M Iqbal Choudhary Source Type: research
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?
Expert Rev Clin Pharmacol. 2023 Feb 1. doi: 10.1080/17512433.2023.2176301. Online ahead of print.ABSTRACTINTRODUCTION: The aminoadamantanes amantadine and memantine are well known. They mainly act as N-methyl-D-aspartate antagonists.AREAS COVERED: The antiviral drug amantadine moderately ameliorates impaired motor behavior in patients with Parkinson's disease. Memantine provides beneficial effects on memory function in patients with advanced Alzheimer's disease already treated with acetylcholine esterase inhibitors. Both compounds counteract impaired monoamine neurotransmission with associated symptoms, such as depression....
Source: Pharmacological Reviews - February 2, 2023 Category: Drugs & Pharmacology Authors: Thomas M üller Peter Riederer Wilfried Kuhn Source Type: research
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?
Expert Rev Clin Pharmacol. 2023 Feb 1. doi: 10.1080/17512433.2023.2176301. Online ahead of print.ABSTRACTINTRODUCTION: The aminoadamantanes amantadine and memantine are well known. They mainly act as N-methyl-D-aspartate antagonists.AREAS COVERED: The antiviral drug amantadine moderately ameliorates impaired motor behavior in patients with Parkinson's disease. Memantine provides beneficial effects on memory function in patients with advanced Alzheimer's disease already treated with acetylcholine esterase inhibitors. Both compounds counteract impaired monoamine neurotransmission with associated symptoms, such as depression....
Source: Expert Review of Clinical Pharmacology - February 2, 2023 Category: Drugs & Pharmacology Authors: Thomas M üller Peter Riederer Wilfried Kuhn Source Type: research
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?
Expert Rev Clin Pharmacol. 2023 Feb 1. doi: 10.1080/17512433.2023.2176301. Online ahead of print.ABSTRACTINTRODUCTION: The aminoadamantanes amantadine and memantine are well known. They mainly act as N-methyl-D-aspartate antagonists.AREAS COVERED: The antiviral drug amantadine moderately ameliorates impaired motor behavior in patients with Parkinson's disease. Memantine provides beneficial effects on memory function in patients with advanced Alzheimer's disease already treated with acetylcholine esterase inhibitors. Both compounds counteract impaired monoamine neurotransmission with associated symptoms, such as depression....
Source: Pharmacological Reviews - February 2, 2023 Category: Drugs & Pharmacology Authors: Thomas M üller Peter Riederer Wilfried Kuhn Source Type: research
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?
Expert Rev Clin Pharmacol. 2023 Feb 1. doi: 10.1080/17512433.2023.2176301. Online ahead of print.ABSTRACTINTRODUCTION: The aminoadamantanes amantadine and memantine are well known. They mainly act as N-methyl-D-aspartate antagonists.AREAS COVERED: The antiviral drug amantadine moderately ameliorates impaired motor behavior in patients with Parkinson's disease. Memantine provides beneficial effects on memory function in patients with advanced Alzheimer's disease already treated with acetylcholine esterase inhibitors. Both compounds counteract impaired monoamine neurotransmission with associated symptoms, such as depression....
Source: Expert Review of Clinical Pharmacology - February 2, 2023 Category: Drugs & Pharmacology Authors: Thomas M üller Peter Riederer Wilfried Kuhn Source Type: research
